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This  paper  speculates  on the  role  of infection  in modifying  a  young  child’s  risk  of promoting  precursor
B-cell  acute  lymphoblastic  leukemia  (ALL).  It is suggested  that  the heat  shock  instigated  by  infections,
particularly  in infancy,  stimulates  Th1  pro-inﬂammatory  cytokines  and  an  apoptosis-inhibitory  environ-
ment.  This  infective  stress  also  increases  the number  of  cooperating  oncogenic  mutations  in  pre-leukemic
cells,  especially  if  the  primary  adaptive  immune  response  is  delayed.  The  glucocorticoid  release  that
follows leads  to  acute  thymic  involution,  a  decline  in  antitumor  immunity,  and  maturation  arrest  of  B-
lymphocytes.  The  infective  lymphoid  recovery  hypothesis  addresses  an  apparent  contradiction–that  a
non-hygienic  environment  primes  the  adaptive  immune  response  and  is protective  against  childhoodtiology
eat shock
mmune reconstitution
nfections
ALL,  while  multiple  infections  occurring  later  increase  the  risk  of  childhood  ALL.  In afﬂuent  (compared
to  less-afﬂuent)  societies,  the  characteristic  ALL  incidence  peak  in early  childhood,  and  the shortened
time  to diagnosis,  arise  from  surviving  recurrent  infections  and  the accumulated  loss  and  recovery  of
lymphoid  tissue.  Evidence  supporting  the  hypothesis,  such  as  the  role  of  lymphoid  tissue  reconstitution
cytokines  that  stimulate  proliferation  stress  on  B-cell  progenitors,  comes  from  the  study  of  children  with
congenital  syndromes  that  are  susceptible  to  leukemia.Crown Copyright © 2011 Published by Elsevier Ltd.  
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Precursor B-cell acute lymphoblastic leukemia (PBC-ALL), also
nown as common ALL, is the most prevalent form of ALL in chil-
ren (1–15 years), with an incidence that characteristically peaks
etween 2 years and 5 years of age [1].  Another ALL subset, T-cell
LL, is diagnosed uniformly throughout childhood. Although cancer
s generally a multistage process, there is merit in explaining ALL
clones (∼30%), as well as the fusion genes t(12;21) [TEL-AML1]
and t(1;19) [E2A-PBX1], among other genetic aberrations. Covert
leukemic clones initiated pre-natally from primitive hematopoietic
cells are present both in those who do, and those in the major-
ity who  do not, develop the disease [4].  These pre-leukemic cells
require additional cooperating oncogenic lesions to be promoted
Open access under CC BY-NC-ND license.n terms of a two-stage initiation-promotion model, with initiation
utations mainly taking place in utero [2,3]. Childhood PBC-ALL
s most commonly associated with high-hyperdiploid leukemic
∗ Corresponding author. Tel.: +1 613 584 3311x44755.
E-mail address: Richard.Richardson@mcgill.ca
145-2126 Crown Copyright © 2011 Published by Elsevier Ltd.         
oi:10.1016/j.leukres.2011.07.023
Open access under CC BY-NCto an overt and full leukemic phenotype [5].
The range of epidemiological factors that are associated with
ALL suggests a multifactorial promotional etiology with a poten-
tial genetic component. Risk factors associated with childhood
ALL include ionizing radiation, certain chemotherapy agents, pes-
ticides, and low birth order (e.g., being a ﬁrst-born) among others
[6–8]. Nearly a century ago Ward proposed that infections played a
role in the etiology of childhood ALL [9].  Instead of cell targeting
-ND license.
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for an infectious heat shock response and other factors identi-
ﬁed that promote pre-leukemic cells to overt PBC-ALL. Lastly, the
infective lymphoid recovery hypothesis is compared with other
published hypotheses, demonstrating the ability of the infectiveig. 1. Schematic diagram of major activation (continuous lines) and suppression (
esponse times to infection are rapid (minutes to 4 h), intermediate (around 2 d), or
ypothalamic-pituitary-adrenal; NK: natural killer; and see main text for other abb
y infectious diseases [10], as occurs in Burkitt lymphoma, the
remise of this paper is that the promotion of PBC-ALL is an aber-
ant immunological response to pre-natal infections, and especially
ost-natal infections that have a peak occurrence at 10 months old
n an afﬂuent country such as the U.K. [11]. Intracellular pathogens
uch as viruses, which invoke a particularly rapid innate immune
esponse, are the cause of approximately 90% of acute febrile ill-
esses in infants and young children [12]. There is a risk—especially
n neonates—that serious infections (including common extracel-
ular bacteria e.g., S. pneumoniae and H. inﬂuenzae)  may  put the
daptive immune system and B-cells under proliferative stress
Fig. 1).
The infective heat shock and lymphoid tissue recovery hypoth-
sis (herein called the ‘infective lymphoid recovery hypothesis’)
resented here proposes that pre-leukemic cells may  be promoted
o overt PBC-ALL by common infections, primarily in young chil-
ren, according to the following etiologic process:
a) hygienic conditions in infancy inhibit early immune priming,
thus reducing the efﬁcacy of the secondary immune response
to later infections [13,14],
b) infectious fevers induce expression of heat shock proteins (HSP)
and pro-inﬂammatory T helper 1 (Th1) cell cytokines, both of
which are conducive to cell survival and a hypermutatable state
[15],
(c) cytokine activation of the hypothalamic–pituitary–adrenal
axis, resulting in infection-related glucocorticoid release and
transient involution of the thymus and other lymphoid organs,
causes a decline in antitumor immunosurveillance and the mat-
uration arrest of B-cells,
d) recurrent infections lead to cumulatively degraded stress
responses and higher homeostatic cytokine levels as the
body tries to reconstitute the atrophied/maturation-stalled
lymphoid tissue, thereby stimulating the proliferation of pre-
malignant precursor B-cells, and lines) regulatory pathways of a child’s defensive response to microbial infections.
3 d or more). The bottom bar indicates potential effects on pre-leukemia cells. HPA:
ions.
(e) later release of Th2 cytokines augments a secondary and adap-
tive immune response, putting additional proliferative stress on
bone marrow hematogones (benign B-lymphocyte precursors)
and pre-leukemic cells, thereby advancing overt leukemia.
The infective lymphoid recovery hypothesis is based on a three-
part methodology (Fig. 2), and an extensive review of the associated
literature, that in: Section 1 reconciles seemingly contradictory
protective and promoting evidence concerning infectious expo-
sure, hereafter called the ‘infection paradox’; Section 2 ascertains
the etiologic factors associated with individuals with congenital
syndromes who are susceptible to developing childhood leukemia,
especially PBC-ALL; and Section 3 further explores the evidenceFig. 2. The three major elements of the infective lymphoid recovery hypothesis.
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ymphoid recovery hypothesis to explain certain PBC-ALL charac-
eristics, such as peak incidence at 2–5 years of age.
. Infection paradox
This section provides an explanation for the often contrary sci-
ntiﬁc evidence on the involvement and timing of infections in
BC-ALL etiology. Epidemiological studies and hypotheses identify
 signiﬁcant but low risk of childhood leukemia from in utero infec-
ious exposure during pregnancy [7,16].  McKinney et al. [17] found
hat, in British children, ALL was strongly associated with post-natal
iral diseases (e.g., chicken pox, rubella, measles and inﬂuenza)
ccurring within 6 months of birth, with the latent period to malig-
ancy ranging from 2.5 years to 5.5 years. Children over the age of 9
iagnosed with lymphoid cancers were associated with 4 or more
pisodes of illness (e.g., inﬂuenza). A later U.K. case control study
18] found that children aged 2–5 years diagnosed with ALL had an
xcess of clinically diagnosed (e.g., presence of fever) viral and bac-
erial infections in infancy, especially during the neonatal period
less than 1 month old). Two or more infections caused ALL to be
iagnosed earlier than for a single episode.
The apparent importance of infective mechanisms in the pro-
otion of childhood ALL led Kinlen [19], Greaves [14], and
chmiegelow et al. [20] to postulate the ‘population-mixing the-
ry’, the ‘delayed ﬁrst exposure hypothesis’, and the ‘adrenal
ypothesis’, respectively; the latter is examined in the Discus-
ion. Kinlen’s population-mixing theory proposed that workers
oving to isolated communities expose immunologically naïve
nfants to speciﬁc infections and a higher risk of ALL [19]. Greaves’
elayed ﬁrst exposure (or ‘delayed infection’) hypothesis is based
n the necessity of an infectious challenge for the newborn’s
aïve immune system to mature and counter childhood ALL [14].
ccordingly, infants who experience a delayed exposure to infec-
ious agents are at greater risk of an abnormal lymphoproliferative
esponse. Support for Greaves’ hypothesis comes from studies
sserting that formal daycare (as compared to home care) and
ncreasing birth order provide infants with a signiﬁcant protec-
ive effect against ALL due to an early, elevated infectious exposure
7,21,22]. Yet, as discussed above, there is also seemingly contrary
vidence that multiple or prolonged episodes of common infections
n infancy promote the transition to overt ALL later in childhood
17,18]. The infective lymphoid recovery hypothesis addresses this
nfection paradox by presuming that mild infections early in life
rime the immune adaptive response, whereas later recurrent
nfections in childhood provide the conditions conducive for the
ccumulation of cooperating oncogenic mutations necessary for
he promotion of PBC-ALL [5].
able 1
haracteristics relevant to childhood leukemia are compared for various conditions and a
iterature.
Conditions Prone to
infections
Abnormal (or absent)
thymus
Ataxia–telangiectasia [33,34]
√ √
(Mostly absent)
Breastfeeding (absence of) [36–38]
√ √
Smaller
Bloom syndrome [29]
√ 
Congenital heart defects [32]
√ √
(Absent)
DiGeorge syndrome [35]
√
Down syndrome [39–42,48]
√ √ 
Fanconi anemia [30]
√ 
Infections (in utero and in infancy)
[16–18,59,61]
√ 
Ionizing radiation [6,25,27]
√
High dose only
Neuroﬁbromatosis [23]
Shwachman–Diamond syndrome [49]
LL: acute lymphoblastic leukemia, AML: acute myeloid leukemia, BM: bone marrow, JMrch 35 (2011) 1425– 1431 1427
2. Etiologic factors identiﬁed from congenital syndromes
and other conditions
Congenital syndromes and other conditions (e.g., irradiation)
that are associated with an excess risk of childhood leukemia
were examined in order to identify the etiologic factors that
increase vulnerability to acute myeloid leukemia (AML), and partic-
ularly to PBC-ALL. Table 1 lists the relationship between childhood
leukemia and the following conditions: Down Syndrome (DS);
primary immunodeﬁciency disorders (i.e., ataxia–telangiectasia
and DiGeorge syndrome); chromosome fragility disorders (i.e.,
Bloom syndrome and Fanconi anemia); and Shwachman–Diamond
syndrome and neuroﬁbromatosis (the latter arising from a tumor-
suppressor gene mutation) [23]. The association of childhood ALL
with lymphoid organ changes was reviewed to determine if a pos-
itive association was linked to a congenital (primary) feature or to
atrophy acquired due to (secondary) infection. Breastfeeding was
also considered because of its role in partially negating the risk of
childhood leukemia.
Ionizing radiation is the best-documented environmental risk
factor that is signiﬁcantly linked to childhood leukemia. Even so,
past risk assessments of leukemia and bone cancer induced by
radionuclide intakes have been hampered by assuming the dose
and risk to quiescent and active (hematopoietic and mesenchymal)
stem cells is the same [24]. The epidemiological evidence is gen-
erally positive for both in utero and post-natal exposure causing
excessive instances of ALL and AML, with a weaker association as
age increases [6,25,26]. In addition, high-dose treatments admin-
istered before 1950 to reduce purportedly enlarged thymuses in
infants led to an elevated incidence of thyroid cancer and leukemia
[27]. Even for low radiation doses of the whole body, there is the
potential for ALL to be initiated by DNA double strand breaks in
utero and promoted post-natally, perhaps by a heat shock response
that furthers inﬂammation and inhibits apoptosis [28].
Infections can be a concern in the chromosome fragility dis-
orders Bloom syndrome and Fanconi anemia, although thymus
abnormalities for either disorder are not prominent in the litera-
ture. Leukemia develops in about 10–15% of both Bloom syndrome
and Fanconi anemia patients. German [29] reports a similar number
of acute lymphocytic and myelogenous leukemia cases for Bloom
syndrome. There is little evidence of an ALL incidence peak at 2–5
years for either disorder. In Fanconi anemia patients, AML  is the
dominant form of leukemia (>90% of cases) and is related to the
premature senescence of hematopoietic stem cells and the occur-
rence of myelodysplastic syndrome (MDS) [30,31]. This suggests
that senescence of the hematopoietic stem cell pool may  promote
AML, yet inhibit the promotion of ALL.
ssessed as observed (
√
) or not observed (no symbol) as a prominent feature in the
Abnormal non-thymic
lymphoid tissue
Excessive rates of ALL
with peak 2–5 y
Excessive rates of
‘non-PBC ALL’
leukemia
√
S, L
√
T-ALL√ √
AML√
AML
√
BM, S, L
√ √
AML√
BM
√
AML√
BM, S, L
√ √
AML
√
BM, S, high dose only
√ √
AML√ √
AML, JMML, T-ALL√
BM
√
AML
ML:  juvenile myelomonocytic leukemia, L: lymph, S: spleen, and T-ALL: T-cell ALL.
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There are several athymic medical conditions, including con-
enital heart defects, which are present in about 1% of babies at
irth. Within weeks the thymus is generally removed surgically to
epair the heart. Young adults with congenital heart defects have
 T-cell proﬁle similar to elderly non-affected adults 50 years their
enior [32]. The majority (80%) of ataxia-telangiectasia individuals
lso have no thymus; for the 20% with the organ, it resembles that
f a fetus [33]. Hypoplasia of lymphoid tissue and infections are
ommon in ataxia–telangiectasia patients, who are also prone to
eveloping non-hematologic and hematologic neoplasms, includ-
ng T-cell ALL and AML  [34]. The immunological abnormalities of
iGeorge syndrome individuals and their susceptibility to recur-
ent infections may  be attributed to congenital underdevelopment
f the thymus or, rarely, to its complete absence. B-cell matura-
ion and the adult-like production of immunologlobulin-containing
ells does not normally take place in neonates without DiGeorge
yndrome, but surprisingly does take place in neonates with the
yndrome who lack T-suppressor activity [35]. Childhood ALL is not
rominent in these conditions, and therefore it appears that infec-
ions in children who lack a functional thymus are not conducive
o the development of ALL.
Breastfeeding (as compared to formula feeding) can double
hymic size by 4 months of age, improve CD4+ and CD8+ T-
ymphocyte concentrations, and reduce the risk of respiratory tract
nfections in infants by up to two-thirds [36,37]. A meta-analysis
f 14 case-control studies revealed that long-term breastfeeding
educes the risk of childhood leukemia, particularly ALL; although
he results of individual studies are ambiguous probably due to
heir small size [38]. These breastfeeding studies highlight the
mportance of even modest changes in thymic size upon the post-
atal development of immunocompetence and ALL.
For most congenital syndromes susceptible to leukemia, there
s limited data on ALL subtypes and their relative risk; of these con-
itions, DS children are the best studied. DS children are highly
ulnerable to respiratory tract infections and an increased occur-
ence of thymic aberrations [39]. Marked (T- and B-) lymphocyte
epletion has also been observed in the spleen and lymph glands of
S infants perhaps due to congenital factors [40]. It is well known
hat individuals with DS have a greatly elevated risk of childhood
eukemia: the relative risks are about 10–30 times higher than
ontrols [39,41,42].  Neonates with DS exhibit a range of hemato-
ogic abnormalities, including transient leukemia and MDS, both
f which can precede AML. For DS children, the frequency of ALL
s about one and a half times that of AML, as compared to 4:1 for
on-DS children [42].
The vulnerability of DS children to immunological defects and
BC-ALL may  be affected by additional copies of genes on chro-
osome 21, such as the oncogene AML1, and genes of the HSP70
amily and interferon (IFN) receptors [43]. Regarding the latter, DS
ndividuals exhibit increased levels of the Th1 pro-inﬂammatory
ytokine IFN- associated with stimulating the formation of com-
on  lymphoid progenitors [44,45]. IFN-inducible genes indicative
f a viral infection are highly expressed in the hyperdiploid PBC-
LL variant that constitutes a large part of the incidence peak [46].
risomy 21 is present in the bone marrow of all DS individuals, and
t may  not be a coincidence that it is also present in half of non-DS
hildhood ALL cases [47]. Therefore, trisomy 21 could be involved
n promoting ALL in DS and non-DS children, as both groups have
 similar trend in ALL age-speciﬁc incidence rates [48]. A differ-
nce is that the DS peak incidence is more pronounced and the
romotion/latent period possibly shorter than for non-DS.
In summary, a high risk of bone marrow dysfunction is present
n children with chromosome breakage syndromes (i.e. ataxia
telangiectasia, Bloom syndrome and Fanconi anemia), DS and
hwachman-Diamond syndrome [49]. These congenital syndromes
isplay segmental symptoms of accelerated ageing, as does MDS,rch 35 (2011) 1425– 1431
a  disease that can advance to AML, but not ALL. Similarly, thymec-
tomy in congenital heart defect patients and the impaired thymic
processes in ataxia–telangiectasia, DiGeorge syndrome and DS,
prematurely age the immune system and downgrade the abil-
ity to countermand infections and tumors [32]. Nevertheless,
the apparent lack of excessive rates of ALL in children with
ataxia–telangiectasia, congenital heart defects, and DiGeorge syn-
drome implies that the absence or removal of an infant’s thymus
is not enough in itself to induce PBC-ALL (Table 1). DS studies
indicate an abnormal infective Th1 signaling response to an IFN-
-dependent immunosurveillance mechanism. Therefore, etiologic
factors conducive to the promotion of childhood ALL appear to be
recurrent infections, followed by thymic atrophy, lymphoid tissue
abnormalities, sustained proliferative signaling and reconstitution
of lymphoid tissue.
3. Infective heat shock response and lymphoid tissue
recovery
Natural stressors, such as heat stress, malnutrition and infection,
can invoke a heat shock response. Evidence is presented below to
demonstrate that recurrent infective and heat shock responses in
the fetus or infant are linked to defective differentiation of blood
cells, overproduction of immature B-lymphocytes, and inhibition
of B-cell death—genetic hallmarks of PBC-ALL [5].  HSPs generated
by the host upon invasion by viruses and bacteria (or the bacteria’s
own  HSPs) rapidly activate the innate immune system. This is fol-
lowed by a hypothalamic–pituitary–adrenal response [50], as well
as acute involution of the thymus (alternatively called ‘transient
involution’) and of other lymphoid organs and tissues.
A mutation in the gatekeeper p53 gene—the most common
mechanism by which a neoplasm escapes apoptosis—is weakly
associated with leukemia. Only 5% of childhood ALL cases at diagno-
sis exhibit p53 mutations, which is among the lowest p53 mutation
incidence of all cancers [51]. HSPs may  be a more prevalent means
of avoiding cell death in leukemia. An elevated expression of HSPs
has been detected in various forms of leukemia (e.g., high constitu-
tive expression of HSP90 is associated with the proliferation of ALL
cells) [52]. Small heat shock protein HSP27 isoforms are associated
with common ALL in a uniquely characteristic manner, as HSP27
is synthesized during both normal and abnormal development of
immature lymphoid cells at the pre-B-cell stage of differentia-
tion [53]. There is a greater frequency of human leukocyte antigen
(HLA) haplotypes and HLA-complex-linked HSP70 genes in boys
as compared to girls [54]. This, and males’ greater susceptibility
to infections and stress, may  possibly inﬂuence the incidence of
childhood ALL being slightly higher in boys than in girls [55].
HSP60, HSP70, and HSP90 induce macrophages and other cells
to release Th1 pro-inﬂammatory cytokines, including tumor necro-
sis factor- (TNF-),  interleukin-2 (IL-2) and IL-12 [56]. About
two days after a heat shock response, Th1 cytokines stimulate
increased glucocorticoid secretion during the post-stress recov-
ery period, thereby causing transient involution of the thymus
and limiting over-activity by the immune and inﬂammatory path-
ways. Chronic (particularly bacterial) infections and heat shock
result in cumulative stress-induced weakening of the glucocorti-
coid receptor-mediated recovery response [57]. Thymic involution
and thymic lymphocyte depletion measured in fetuses and young
children have been shown to be related to the duration of pre-natal
and post-natal acute infections, respectively [58,59]. In addition,
limited atrophy in the spleen and lymph nodes was observed
in those who died after a period of acute illness [58,60]. These
anatomical ﬁndings show that after sustained pre- or post-natal
infections, there is cumulative degradation of lymphoid tissue
requiring reconstitution.
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Infants experiencing infections exhibit thymic involution and
an be expected to have lesser immunosurveillance by CD4+ and
D8+ cells, similar to formula-fed infants [36]. In addition, the
ower thymic function affects the ability to complete the B-cell
aturation process and to generate high-afﬁnity memory cells
nd antibody formation [61]. Hematogones make up on average
ne-third of the bone marrow cells of living pre-term neonates
62]. Normally, marrow lymphocyte maturation is probably trig-
ered by birth, with ten times fewer hematogones at 2–5 years
ld. Hematogones are especially prominent in children exhibiting
 serious complication (e.g., acute thrombocytopenic purpura) after
iral infections such as measles and chicken pox [63]. Congenital
ytomegalovirus (CMV) infections are associated with post-natal,
xcessive hematogones of immature benign cell types similar to
hose characteristic of infant ALL (a distinct PBC-ALL group, most
ith MLL  gene rearrangements) that usually occurs in infants, 0–1
ear old [64]. Further evidence of arrested bone marrow matu-
ation is provided by post-uterine CMV  infections preceding the
bservation of hematogones of PBC-ALL-like cell types [65]. There-
ore, perinatal infections seem to be an opportunistic mechanism
or bone marrow to undergo maturation arrest and acquire the
mmunophenotypic aberrancies characteristic of PBC-ALL.
Key components of any PBC-ALL etiological hypothesis are the
iological mechanisms that can stimulate excessive B-cell prolif-
ration. A B-cell response is not limited to bacterial infections; for
nstance, the inﬂuenza virus induces IFN-mediated B-cell activa-
ion and the production of antiviral antibodies [66]. In addition,
espiratory syncytial virus—the principal etiologic agent of res-
iratory infections in infants and young children—provokes both
 heat shock and Th2 response [67]. There is also evidence that
ysregulation of the transforming growth factor- (TGF-) path-
ay, a Th2 cytokine produced in response to infection and that
ccelerates thymic involution, is involved in the promotion of TEL-
ML1-positive ALL [68].
Lastly, there is evidence of B-cell proliferative signaling by the
omeostatic agent IL-7, which is associated with infections and
econstitutions of maturation-stalled or atrophied lymphoid tis-
ues. IL-7 serum levels are elevated after infections in general, and
ugment reconstitution of the thymus and spleen [69,70].  Perhaps
elated to DS’s congenital vulnerability to childhood ALL, IL-7 levels
re similarly raised in DS individuals aged 4–25 years old who have
o acquired diseases [71]. IL-7 not only stimulates the proliferation
f normal B- and T-cell precursors and T-lymphocytes, but it also
cts as a growth factor for PBC-ALL and T-cell ALL [72].
In summary, the seemingly contradictory aspects of infection
nd PBC-ALL risk have been explained; the etiological factors,
erived from conditions with varying susceptibility to childhood
eukemia, have been identiﬁed; and further evidence that supports
he infective lymphoid recovery hypothesis has been presented.
he hypothesis asserts that recurrent infection-driven heat shock
nd lymphoid involution is followed by an IL-7-mediated immune
ecovery that places increased proliferative pressure on immature
-cells, which in turn promotes the transformation of pre-leukemic
ells into overt PBC-ALL.
. Comparison of PBC-ALL etiological hypotheses
The adrenal hypothesis, as recently proposed by Schmiegelow
t al. [20], explains the lower risk of common ALL experienced
y children exposed to early infections by citing changes in the
ypothalamic–pituitary–adrenal axis. This theory maintains that
nfections raise glucocorticoid (e.g., cortisol) levels, which effec-
ively induce apoptosis of thymocytes, reduce proliferative stress,
nd lead to the apoptosis of pre-existing leukemic cells. Strong
vidence is given in support of the adrenal hypothesis—namely,rch 35 (2011) 1425– 1431 1429
that the administration of glucocorticoid (either on its own or as
part of an anti-inﬂammatory, immunosuppressive and chemother-
apeutic ALL agent) can produce a four-log reduction of malignant
lymphoblasts in children [73]. However, the adrenal hypothesis
does not address the fact that after infection-mediated atrophy
of lymphoid tissue, there is reconstitution that puts proliferative
stress on apoptotic-resistant, pre-leukemic cells. Also, the adrenal
hypothesis only accounts for the ﬁrst of two seemingly contra-
dictory mechanisms of the infection paradox—that infections can
provide both a protective and promotional mechanism in PBC-ALL
etiology [14,17–19].
The infective lymphoid recovery hypothesis, however, is able
to reconcile both components of the infection paradox. It asserts
that protection from PBC-ALL is afforded by early, mild infections
that prime an adaptive immune response. Any delay in this prim-
ing (more likely to occur in hygienic, socially isolated, and afﬂuent
societies) places greater reliance, when defending against infec-
tious pathogens, on heat shock activation of the innate immune
response and on a pro-inﬂammatory state. However, later recurrent
exposure to infections—especially in infancy—has an accumula-
tive effect on activation of the hypothalamic–pituitary–adrenal axis
and transient involution of lymphoid tissues, which may enhance
the selection of a resistant, pre-leukemic strain. The subsequent
reconstitution of lymphoid tissues places proliferating stress on
hematogones and pre-leukemic cells.
Greaves [8] rightly states that any credible hypothesis on the
etiology of childhood ALL needs to explain why  ALL incidence rates
in children increase by ∼1% per annum, and why the incidence
peak at 2–5 years is more prominent in afﬂuent societies as com-
pared to populations with poor socio-economic conditions and high
child mortality rates [7,10,20,74]. One factor that should be con-
sidered is that in less-afﬂuent or developing countries, families are
generally larger and live in closer quarters; this provides a par-
allel environment to the daycare centers in the developed world
that immunologically prime young children and protect against
childhood ALL [21,22]. Another factor likely inﬂuencing the low
ALL incidence rates in children of developing countries is their
high rate of breastfeeding [75], which furthers thymic enlarge-
ment that improves the immunosurveillance of pre-leukemic cells
and lessens the need for lymphoid tissue reconstitution. On the
other hand, afﬂuence and improved healthcare lead to more infants
surviving recurrent infectious episodes (especially important to
the more vulnerable, such as those with DS) [25] and living to
experience accumulated lymphoid tissue atrophy and recovery,
thereby putting greater proliferative stress on hematogones and
pre-leukemic cells. The infective lymphoid recovery hypothesis
predicts that this intense transformative pressure shortens the
promotion/latent period, concatenating the PBC-ALL diagnoses
towards late infancy (the period of maximum infection rates) [11]
and resulting in a steeper and more pronounced peak incidence.
The widely accepted hygiene hypothesis explains the elevated
incidence of allergies in developed countries based on lesser expo-
sure to infections during early childhood [13]. It is compatible
with Greaves’ [14] hypothesis (as well as the infective lymphoid
recovery hypothesis), which contends that the risk of childhood
ALL is reduced by exposure to priming infections in early life.
Notwithstanding, Schmiegelow and colleagues [76] conducted a
meta-analysis of 11 case–control studies and found an inverse asso-
ciation between ALL and atopic allergies in children (e.g., asthma,
eczema, and hay fever). Similarly, DS cases susceptible to ALL are
associated with a signiﬁcant deﬁcit of asthma [41]. Allergies involve
an excessive Th2 anti-inﬂammatory response and class-switching
to enhance the production of IgE antibodies. A possible expla-
nation for the inverse relationship is that PBC-ALL is associated
more strongly with a heat shock mediated Th1 response and lym-
phoid tissue reconstitution, as compared to a Th2 response. Further
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upport for a Th1 response being linked to PBC-ALL is provided by
bservations of malnourished children without infections from a
eveloping country, which generally have low incidences of ALL
50]. Although starvation is associated with a heat shock response
hese children do not have elevated levels of serum cortisol and Th1
ro-inﬂammatory cytokines.
. Predictions and conclusion
The infective lymphoid recovery hypothesis generates testable
redictions. One is that the risk of PBC-ALL will be generally
nhanced in those young children who experience recurrent infec-
ions and elevated levels of IL-7 indicating a lymphoid recovery.
nother prediction is that neonates and infants, compared to older
hildren, will exhibit a greater gain in the frequency of oncogenic
utations due to infections [15]. Issues warranting further study
nclude determining if the protective and promotional facets of
he infection paradox apply differently to PBC-ALL immunologi-
al (e.g., pro-B, pre-B) or cytogenetic variants, as suggested by high
irus-mediated INF- levels associated with the hyperdiploid sub-
ype [46]. A better understanding of PBC-ALL etiology would be
ained from collecting further statistical data on ALL subtypes for
ongenital syndromes and other vulnerable conditions.
In conclusion, a signiﬁcant aspect of the infective lymphoid
ecovery hypothesis is that it appears to explain the infection para-
ox and the prominence of the ALL peak incidence as being due to
he shortening of the promotion/latent period by surviving multi-
le infections and an over-expressive lymphoid-recovery response.
t is hoped that this hypothesis will encourage further research and
esting of the etiological process proposed, thereby leading to a
etter understanding and treatment of common childhood ALL.
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